NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Can PRP Reduce Pro-Inflammatory Biomarkers Following ACL Injury

Phase 2

Withdrawn

Conditions: ACL - Anterior Cruciate Ligament Rupture
ACL Injury

Interventions: Biological: Platelet Rich Plasma
Other: Saline Placebo

First Posted Date: 2018-01-03

Last Posted Date: 2024-04-15

Lead Sponsor: NYU Langone Health

Registration Number: NCT03389685

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Efficacy of a Gluten-free Diet in Difficult to Manage Nephrotic Syndrome: Utility of Plasma Zonulin Levels as a Predictive Biomarker

Completed

Conditions: Nephrotic Syndrome

Interventions: Other: Implementation of a gluten-free diet

First Posted Date: 2017-12-29

Last Posted Date: 2021-06-22

Lead Sponsor: NYU Langone Health

Target Recruit Count: 13

Registration Number: NCT03387176

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

HCV Positive Heart Donors

Phase 4

Completed

Conditions: Heart Failure

Interventions: Combination Product: Transplant with HCV positive donor, followed by surveillance and treatment of viremia

First Posted Date: 2017-12-26

Last Posted Date: 2021-02-03

Lead Sponsor: NYU Langone Health

Target Recruit Count: 25

Registration Number: NCT03382847

Locations: 🇺🇸
NYU Langone Transplant Institute, New York, New York, United States

3D MR Versus 3D CT for Glenohumeral Arthritis

Not Applicable

Completed

Conditions: Arthritis
Glenohumeral Osteoarthritis

Interventions: Diagnostic Test: 3-dimensional (3D) magnetic resonance (MR) imaging
Diagnostic Test: 3D computed tomography (CT) imaging

First Posted Date: 2017-12-20

Last Posted Date: 2021-03-25

Lead Sponsor: NYU Langone Health

Target Recruit Count: 31

Registration Number: NCT03379545

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma

Phase 2

Completed

Conditions: MGMT-unmethylated Glioblastoma (GBM)
GBM

Interventions: Drug: Nivolumab
Drug: Ipilimumab
Radiation: Radiation Therapy (RT)

First Posted Date: 2017-12-11

Last Posted Date: 2022-07-01

Lead Sponsor: NYU Langone Health

Target Recruit Count: 10

Registration Number: NCT03367715

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate Cancer

Not Applicable

Terminated

Conditions: Prostate Cancer

Interventions: Device: Artemis™ software system

First Posted Date: 2017-12-08

Last Posted Date: 2022-03-23

Lead Sponsor: NYU Langone Health

Target Recruit Count: 46

Registration Number: NCT03366792

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

The Poweroff Sleep Study

Not Applicable

Completed

Conditions: Sleep

Interventions: Dietary Supplement: Placebo Capsule
Dietary Supplement: POWEROFF Capsule

First Posted Date: 2017-12-06

Last Posted Date: 2018-05-22

Lead Sponsor: NYU Langone Health

Target Recruit Count: 60

Registration Number: NCT03364101

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Optimizing Treatment Effects on OSA-related Clinical and Patient-centered Outcomes Among Blacks

Not Applicable

Withdrawn

Conditions: Obstructive Sleep Apnea

Interventions: Behavioral: OSA Treatment
Behavioral: Standard Videos
Behavioral: Tailored Videos

First Posted Date: 2017-11-28

Last Posted Date: 2022-02-09

Lead Sponsor: NYU Langone Health

Registration Number: NCT03354520

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Resident Observed Burnout After Daily Supplementation With Coffee

Not Applicable

Completed

Conditions: Burnout, Professional

Interventions: Dietary Supplement: Daily Supplementation with Coffee

First Posted Date: 2017-11-28

Last Posted Date: 2018-05-22

Lead Sponsor: NYU Langone Health

Target Recruit Count: 39

Registration Number: NCT03355144

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

The Dementia Symptom Management at Home Program Hospice Edition

Not Applicable

Terminated

Conditions: Dementia

Interventions: Behavioral: DSM-H Hospice Edition performance improvement program
Behavioral: Usual Care

First Posted Date: 2017-11-24

Last Posted Date: 2019-12-04

Lead Sponsor: NYU Langone Health

Target Recruit Count: 2

Registration Number: NCT03352791

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy